Editorial: tradipitant has promise for treating gastroparesis but leaves gastric function alone
- PMID: 35804474
- DOI: 10.1111/apt.17090
Editorial: tradipitant has promise for treating gastroparesis but leaves gastric function alone
Comment in
-
Editorial: tradipitant has promise for treating gastroparesis but leaves gastric function alone-authors' reply.Aliment Pharmacol Ther. 2022 Aug;56(3):542-543. doi: 10.1111/apt.17098. Aliment Pharmacol Ther. 2022. PMID: 35804471 No abstract available.
Comment on
-
The metoclopramide black box warning for tardive dyskinesia: effect on clinical practice, adverse event reporting, and prescription drug lawsuits.Am J Gastroenterol. 2013 Jun;108(6):866-72. doi: 10.1038/ajg.2012.300. Am J Gastroenterol. 2013. PMID: 23735907
References
REFERENCES
-
- Carbone F, Van den Houte K, Clevers E, Andrews CN, Papathanasopoulos A, Holvoet L, et al. Prucalopride in gastroparesis: a randomized placebo-controlled crossover study. Am J Gastroenterol. 2019;114(8):1265-74. https://doi.org/10.14309/ajg.0000000000000304
-
- Compton, K. (2022). Reglan & tardive dyskinesia. Drug Watch. https://www.drugwatch.com/reglan/. Accessed June 1, 2022.
-
- Ehrenpreis ED, Deepak P, Sifuentes H, Devi R, du H, Leikin JB. The metoclopramide black box warning for tardive dyskinesia: effect on clinical practice, adverse event reporting, and prescription drug lawsuits. Am J Gastroenterol. 2013;108(6):866-72. https://doi.org/10.1038/ajg.2012.300
-
- Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L American College of Gastroenterology. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108(1):18-37; quiz 38. https://doi.org/10.1038/ajg.2012.373
-
- Cangemi DJ, Lacy BE. Gastroparesis. Curr Opin Gastroenterol. 2021;37(6):596-601. https://doi.org/10.1097/MOG.0000000000000782